Cadrenal Therapeutics 空头股数下跌，随着主要投资者购买股票，股价上涨。 Cadrenal Therapeutics sees short interest drop, shares rise as major investor buys stock.

Cadrenal Therapeutics的空头股数在2月份大幅下跌了28.9%，3月17日的股价上涨了0.20美元，至19.29美元。 Cadrenal Therapeutics saw a significant 28.9% drop in short interest in February, with shares trading up $0.20 on March 17th to $19.29. 该公司的重点是为心血管疾病开发Tecarfarin,Geode Capital Management LLC也在Q4购买了10 554股股票。 The company, focused on developing Tecarfarin for cardiovascular conditions, also saw a purchase of 10,554 shares by Geode Capital Management LLC in Q4. 同时,2月份,对Cyclo治疗疗法的短期兴趣减少了26.7%,其主要药物Trappsol Cyclo在第三阶段对Niemann-Pick C型疾病进行试验,对阿尔茨海默氏症进行二级b级试验。 Meanwhile, short interest in Cyclo Therapeutics decreased by 26.7% in February, with its lead drug Trappsol Cyclo in Phase III trials for Niemann-Pick Type C disease and Phase IIb for Alzheimer's.